Dr. Paul Kenneth Brownstone, MD
Claim this profileAlpine Clinical Research Center
Studies Alzheimer's Disease
2 reported clinical trials
4 drugs studied
Affiliated Hospitals
Clinical Trials Paul Kenneth Brownstone, MD is currently running
Donanemab
for Alzheimer's Disease
This trial is testing donanemab, a medication aimed at helping people with Alzheimer's Disease by removing harmful protein clumps from their brains. Donanemab has shown promise in reducing these harmful proteins in Alzheimer's disease.
Recruiting1 award Phase 34 criteria
Remternetug
for Alzheimer's Disease
This trial tests remternetug, a drug given by injection or IV, in people with early Alzheimer's disease. It aims to find out if the drug is safe and can help improve symptoms or slow down the disease.
Recruiting1 award Phase 34 criteria
More about Paul Kenneth Brownstone, MD
Clinical Trial Related3 years of experience running clinical trials · Led 2 trials as a Principal Investigator · 2 Active Clinical TrialsTreatments Paul Kenneth Brownstone, MD has experience with
- Donanemab
- Placebo
- Remternetug (IV)
- Remternetug (SC)
Breakdown of trials Paul Kenneth Brownstone, MD has run
Alzheimer's Disease
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Paul Kenneth Brownstone, MD specialize in?
Paul Kenneth Brownstone, MD focuses on Alzheimer's Disease and other conditions. In particular, much of their work with Alzheimer's Disease has involved treating patients, or patients who are undergoing treatment.
Is Paul Kenneth Brownstone, MD currently recruiting for clinical trials?
Yes, Paul Kenneth Brownstone, MD is currently recruiting for 2 clinical trials in Boulder Colorado. If you're interested in participating, you should apply.
Are there any treatments that Paul Kenneth Brownstone, MD has studied deeply?
Yes, Paul Kenneth Brownstone, MD has studied treatments such as Donanemab, Placebo, Remternetug (IV).
What is the best way to schedule an appointment with Paul Kenneth Brownstone, MD?
Apply for one of the trials that Paul Kenneth Brownstone, MD is conducting.
What is the office address of Paul Kenneth Brownstone, MD?
The office of Paul Kenneth Brownstone, MD is located at: Alpine Clinical Research Center, Boulder, Colorado 80301 United States. This is the address for their practice at the Alpine Clinical Research Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.